Kaluzny Arnold D, O'Brien Donna M
Gillings School of Global Public Health, Cecil G. Sheps Center for Health Services Research, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Strategic Visions in Healthcare LLC, New York, NY, United States of America.
Health Policy Open. 2020 Dec;1:100015. doi: 10.1016/j.hpopen.2020.100015. Epub 2020 Oct 13.
In 1971, Congress passed the National Cancer Act, landmark legislation that reorganized the National Institutes of Health's National Cancer Institute (NCI). The Act included a new focus on cancer control, including the requirement that the NCI award research grants and contracts, in collaboration with other public agencies and private industry, to conduct cancer control activities related to the diagnosis, prevention, and treatment of cancer. The requirement placed the NCI at the nexus of a rapidly changing science and a complex and dynamic healthcare delivery system and involved an evolutionary transformation to advance cancer control and cancer care delivery research along the cancer care continuum. Analysis is based on a qualitative ethnographic approach using historical records, oral histories, and targeted interviews. The multimethod approach provided the opportunity to describe the vision, leadership, and struggle to build an infrastructure, expand expertise, and forge collaboration with the NCI and a complex and changing healthcare system. As the 50th anniversary of the National Cancer Act approaches in 2021, the process and these achievements are at risk of being taken for granted or lost in the flow of history. Documenting the process, milestones, and key players provides insight and guidance for continuing to improve cancer care, advance research, and reduce cancer incidence and mortality. Cancer care is a microcosm of the larger healthcare system providing insight and lessons on the importance of developing and maintaining a research infrastructure and the role of multi-level collaboration and partnerships involving both the private and public sectors.
1971年,美国国会通过了《国家癌症法案》,这是一项具有里程碑意义的立法,对美国国立卫生研究院的国家癌症研究所(NCI)进行了重组。该法案包括对癌症控制的新关注,其中要求NCI与其他公共机构和私营企业合作,授予研究补助金和合同,以开展与癌症诊断、预防和治疗相关的癌症控制活动。这一要求使NCI处于快速变化的科学与复杂且动态的医疗保健服务系统的交汇处,并涉及到一场渐进式变革,以在癌症护理连续过程中推进癌症控制和癌症护理服务研究。分析基于一种定性的人种志方法,使用历史记录、口述历史和定向访谈。这种多方法途径提供了机会,来描述构建基础设施、扩大专业知识以及与NCI和复杂多变的医疗保健系统建立合作关系的愿景、领导力和奋斗历程。随着2021年《国家癌症法案》50周年纪念日的临近,这一过程和这些成就有被视为理所当然或在历史长河中被遗忘的风险。记录这一过程、里程碑和关键人物,可为持续改善癌症护理、推进研究以及降低癌症发病率和死亡率提供见解和指导。癌症护理是更大的医疗保健系统的一个缩影,它为发展和维持研究基础设施的重要性以及公私部门多层次合作与伙伴关系的作用提供了见解和经验教训。